Status:
RECRUITING
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
American Headache Society
Conditions:
Idiopathic Intracranial Hypertension (IIH)
Glymphatic System
Eligibility:
All Genders
18-55 years
Brief Summary
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure leading to symptoms like papilledema, headache, and cognitive dysfunction. While the etiology is complex, ...
Eligibility Criteria
Inclusion
- • Refractory IIH patients who require and plan to have a venous sinus stenting
Exclusion
- History of head trauma and shunting or leak repair
- Major concurrent, active non-cephalic pain syndrome
- Contradictions for MRIs
Key Trial Info
Start Date :
March 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06950099
Start Date
March 3 2025
End Date
December 31 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Headache Center
Philadelphia, Pennsylvania, United States, 19107